Fulgent Genetics, Inc. (FLGT), a technology-driven precision medicine company, reported solid financial results for the first quarter of 2025, with strong performance in its core laboratory services business and continued investment in its therapeutic pipeline.
The California-based company provides advanced laboratory testing services and is developing targeted cancer therapies through its proprietary nanoencapsulation platform.
For comments and feedback contact: editorial@rttnews.com
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.